Zhou, Z.; Wang, Y.; Xing, Y.; Pan, S.; Wang, W.; Yang, J.; Wu, W.; Zhou, J.; Huang, L.; Liang, Q.;
et al. Magnolol Inhibits High Fructose-Induced Podocyte Inflammation via Downregulation of TKFC/Sp1/HDAC4/Notch1 Activation. Pharmaceuticals 2024, 17, 1416.
https://doi.org/10.3390/ph17111416
AMA Style
Zhou Z, Wang Y, Xing Y, Pan S, Wang W, Yang J, Wu W, Zhou J, Huang L, Liang Q,
et al. Magnolol Inhibits High Fructose-Induced Podocyte Inflammation via Downregulation of TKFC/Sp1/HDAC4/Notch1 Activation. Pharmaceuticals. 2024; 17(11):1416.
https://doi.org/10.3390/ph17111416
Chicago/Turabian Style
Zhou, Ziang, Yumeng Wang, Yu Xing, Shuman Pan, Wanru Wang, Jie Yang, Wenyuan Wu, Jie Zhou, Luyi Huang, Qiongdan Liang,
and et al. 2024. "Magnolol Inhibits High Fructose-Induced Podocyte Inflammation via Downregulation of TKFC/Sp1/HDAC4/Notch1 Activation" Pharmaceuticals 17, no. 11: 1416.
https://doi.org/10.3390/ph17111416
APA Style
Zhou, Z., Wang, Y., Xing, Y., Pan, S., Wang, W., Yang, J., Wu, W., Zhou, J., Huang, L., Liang, Q., Zhang, D., & Kong, L.
(2024). Magnolol Inhibits High Fructose-Induced Podocyte Inflammation via Downregulation of TKFC/Sp1/HDAC4/Notch1 Activation. Pharmaceuticals, 17(11), 1416.
https://doi.org/10.3390/ph17111416
